SARS-CoV-2 vaccines and biological treatments: dermatological perspectives
Ital J Dermatol Venerol
.
2021 Apr;156(2):118-120.
doi: 10.23736/S2784-8671.21.07055-9.
Authors
Luca Stingeni
1
,
Leonardo Bianchi
2
,
Ketty Peris
3
,
Gabriella Fabbrocini
4
,
Giuseppe Micali
5
,
Piergiacomo Calzavara-Pinton
6
,
Marta Tramontana
1
,
Katharina Hansel
1
;
Board Members of SIDeMaST
Collaborators
Board Members of SIDeMaST
:
Andrea Conti
,
Pasquale Frascione
,
Paolo D Pigatto
,
Bianca Maria Piraccini
,
Franco Rongioletti
,
Pietro Rubegni
Affiliations
1
Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
2
Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy - leonardo.bianchi@unipg.it.
3
Section of Dermatology, Department of Translational Medicine and Surgery, Sacred Heart Catholic University, Rome, Italy.
4
Department of Dermatology, Federico II University, Naples, Italy.
5
Dermatology Clinic, University of Catania, Catania, Italy.
6
Department of Dermatology, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy.
PMID:
33960748
DOI:
10.23736/S2784-8671.21.07055-9
No abstract available
Publication types
Editorial
MeSH terms
Biological Therapy*
COVID-19 / complications
COVID-19 / prevention & control*
COVID-19 / therapy
COVID-19 Vaccines*
Humans
Skin Diseases / complications
Substances
COVID-19 Vaccines